242 related articles for article (PubMed ID: 17692447)
21. The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study.
Selvi Y; Atli A; Aydin A; Besiroglu L; Ozdemir P; Ozdemir O
Hum Psychopharmacol; 2011 Jan; 26(1):51-7. PubMed ID: 21308781
[TBL] [Abstract][Full Text] [Related]
22. Aripiprazole as monotherapy at bedtime was effective for treatment of two cases of obsessive-compulsive disorder and insomnia.
Takaki M
J Neuropsychiatry Clin Neurosci; 2014; 26(3):E64. PubMed ID: 25093799
[No Abstract] [Full Text] [Related]
23. Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder.
Rasmussen SA
Am J Psychiatry; 1984 Oct; 141(10):1283-5. PubMed ID: 6435460
[TBL] [Abstract][Full Text] [Related]
24. Aggravation of schizophrenia by clomipramine in a patient with comorbid obsessive-compulsive disorder.
Margetić B; Aukst-Margetić B; Jakovljević M
Psychopharmacol Bull; 2008; 41(2):9-11. PubMed ID: 18668013
[No Abstract] [Full Text] [Related]
25. When fluvoxamine treats only depression and clomipramine treats only obsessive-compulsive disorder--combine them?
Schaller JL; Behar D; Chamberlain T
J Neuropsychiatry Clin Neurosci; 1998; 10(1):111-3. PubMed ID: 9547477
[No Abstract] [Full Text] [Related]
26. The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients.
Connor KM; Payne VM; Gadde KM; Zhang W; Davidson JR
J Clin Psychiatry; 2005 Jan; 66(1):49-51. PubMed ID: 15669888
[TBL] [Abstract][Full Text] [Related]
27. A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
Milanfranchi A; Ravagli S; Lensi P; Marazziti D; Cassano GB
Int Clin Psychopharmacol; 1997 May; 12(3):131-6. PubMed ID: 9248868
[TBL] [Abstract][Full Text] [Related]
28. Aripiprazole-induced obsessive-compulsive disorder: a report of 2 cases.
Desarkar P; Das A; Nizamie SH
J Clin Psychopharmacol; 2007 Jun; 27(3):305-6. PubMed ID: 17502782
[No Abstract] [Full Text] [Related]
29. Long-term follow-up study of patients with refractory obsessive-compulsive disorder.
Ross S; Fallon BA; Petkova E; Feinstein S; Liebowitz MR
J Neuropsychiatry Clin Neurosci; 2008; 20(4):450-7. PubMed ID: 19196930
[TBL] [Abstract][Full Text] [Related]
30. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
Flament MF; Rapoport JL; Berg CJ; Sceery W; Kilts C; Mellström B; Linnoila M
Arch Gen Psychiatry; 1985 Oct; 42(10):977-83. PubMed ID: 3899048
[TBL] [Abstract][Full Text] [Related]
31. Effects of aripiprazole augmentation in treatment-resistant obsessive-compulsive disorder (a double blind clinical trial).
Sayyah M; Sayyah M; Boostani H; Ghaffari SM; Hoseini A
Depress Anxiety; 2012 Oct; 29(10):850-4. PubMed ID: 22933237
[TBL] [Abstract][Full Text] [Related]
32. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.
Diniz JB; Costa DL; Cassab RC; Pereira CA; Miguel EC; Shavitt RG
J Psychopharmacol; 2014 Jun; 28(6):603-11. PubMed ID: 24288238
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment.
Cavedini P; Erzegovesi S; Ronchi P; Bellodi L
Eur Neuropsychopharmacol; 1997 Feb; 7(1):45-9. PubMed ID: 9088884
[TBL] [Abstract][Full Text] [Related]
34. Intravenous clomipramine for a schizophrenic patient with obsessive-compulsive symptoms.
Poyurovsky M; Weizman A
Am J Psychiatry; 1998 Jul; 155(7):993. PubMed ID: 9659874
[No Abstract] [Full Text] [Related]
35. Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazole.
Englisch S; Esslinger C; Inta D; Weinbrenner A; Peus V; Gutschalk A; Schirmbeck F; Zink M
Clin Neuropharmacol; 2009; 32(4):227-9. PubMed ID: 19644230
[TBL] [Abstract][Full Text] [Related]
36. Successful aripiprazole augmentation in a child with drug-resistant obsessive-compulsive disorder.
Oztürk M; Coskun M
J Clin Psychopharmacol; 2009 Dec; 29(6):607-9. PubMed ID: 19910732
[No Abstract] [Full Text] [Related]
37. Obsessive-compulsive disorder with unusual themes.
Gangdev PS
S Afr Med J; 1996 Jun; 86(6 Suppl):748, 750. PubMed ID: 9180770
[No Abstract] [Full Text] [Related]
38. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H
Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
[No Abstract] [Full Text] [Related]
39. Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment.
McCracken JT; Hanna GL
J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):581-7. PubMed ID: 16190790
[TBL] [Abstract][Full Text] [Related]
40. Aripiprazole in refractory depression?
Carroll BJ
J Clin Psychopharmacol; 2009 Feb; 29(1):90-1; author reply 92-3. PubMed ID: 19142117
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
